Stoke Therapeutics, Inc. STOK
27.02 USD +0.61 (+2.31%)
As ofNov 18, 2026, 3:07 PM EST
25.80 Day range 27.38
22.05 52-week range 40.22
- YTD
- -14.87%
- 1 year
- -6.57%
News
businesswire.com Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) BEDFORD, Mass.--(BUSINESS WIRE)--Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine and…
benzinga.com Stoke Therapeutics Q3 2026 Earnings Call Transcript Stoke Therapeutics (NASDAQ:STOK) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought…benzinga.com Stoke Therapeutics Q3 EPS $(1.08) Misses $(0.93) Estimate, Sales $11.255M Beat $8.185M Estimate Stoke Therapeutics (NASDAQ:STOK) reported quarterly losses of $(1.08) per share which missed the analyst consensus estimate of $(0.93) by 16.13 percent. This is a 66.15 percent decrease over losses…
